Innate Pharma (ADR) - IPHA - stock price prediction, stock price target, analyst ratings from 4 analysts

Innate Pharma (ADR) has a share price target of US$ 6, revenue growth forecast of -25.4%, and profit growth estimate of -15.5% for FY25, based on top 4 analyst calls.